These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3004365)

  • 1. [Cyclic alternating combination chemotherapy of small cell carcinoma of the lung].
    Urata A; Ota K; Nishimura M; Sugiura T; Yamamoto N
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):286-92. PubMed ID: 3004365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung].
    Kinoshita S; Bandou H; Yamashita T; Fukuta K; Yamasaki K; Matsuura A; Shimizu E; Ogura T; Doi H; Nakamura T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):643-8. PubMed ID: 2833178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung].
    Adachi K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Nakata H; Tada A; Aiba K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1617-22. PubMed ID: 6089668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination versus alternating chemotherapy in small-cell lung cancer.
    Lai SL; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for small cell lung cancer.
    Sufarlan AW; Zainudin BM
    Med J Malaysia; 1993 Jun; 48(2):166-70. PubMed ID: 8394502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
    Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
    Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy for small cell carcinoma of the lung: AVN-DVC therapy].
    Bando H; Yamashita T; Matunaga Y; Kinoshita S; Doi H; Ogushi F; Shimada H; Tsubura E; Morioka S; Ishimi H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):888-93. PubMed ID: 6326683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating non-cross resistant chemotherapy for small cell lung cancer.
    Fukuoka M; Takada M; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Kudoh S; Tamai S
    Jpn J Clin Oncol; 1986 Sep; 16(3):261-70. PubMed ID: 3022035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
    Daniels JR; Chak LY; Sikic BI; Lockbaum P; Kohler M; Carter SK; Reynolds R; Bohnen R; Gandara D; Yu J
    J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung.
    Krauss S; Lowenbraun S; Bartolucci A; Buchanan R; Birch R
    Cancer Clin Trials; 1981; 4(2):147-53. PubMed ID: 6265109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.